List

Truth Social post of August 28, 2026

PostStatementPublished 08/28Open the original

Summary

A report is posted that the White House is set to announce new drug pricing deals with biotech companies.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/08/270.0%0.0%
26/08/28−0.4%−0.1%
26/08/31−0.5%−0.4%
26/09/01+1.3%−1.1%
26/09/02+2.3%−0.7%
26/09/03+2.7%+0.3%
26/09/04+1.5%−0.0%
26/09/08−1.0%−0.6%
26/09/09−1.4%−1.0%
26/09/10−1.6%−1.6%
26/09/11−2.0%−0.8%
26/09/14−0.7%−1.2%
26/09/15−1.4%−1.6%
26/09/16−2.0%−1.8%
26/09/17−2.1%−1.0%
26/09/18−2.3%−0.9%
26/09/21−1.9%+0.4%
26/09/22−1.7%+0.4%
26/09/23−2.6%−0.3%
26/09/24−2.5%−0.5%
26/09/25−1.8%+0.2%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Kevin Hern

    Full saleUnitedhealth Group

    $15K–$50K

    Reported 09/25

  • Sheldon Whitehouse

    Partial saleAmgen

    $1K–$15K

    Reported 09/02

  • Pete Sessions

    Full saleAbbVie

    $15K–$50K

    Reported 09/18

  • Thomas H. Kean Jr.

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/12

  • John Boozman

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/11

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • Maria Salazar

    BuyMerck

    $15K–$50K

    Reported 09/09

  • Maria Salazar

    BuyMerck

    $15K–$50K

    Reported 09/09